{"id":"NCT00782509","sponsor":"Boehringer Ingelheim","briefTitle":"12 / 48 wk Pivotal PFT vs PBO in COPD II","officialTitle":"Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 mcg [2 Actuations of 2.5 mcg] and 10 mcg [2 Actuations of 5 mcg]) Delivered by the Respimat® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2010-09","completion":null,"firstPosted":"2008-10-31","resultsPosted":"2014-06-17","lastUpdate":"2014-06-27"},"enrollment":644,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Olodaterol (BI 1744)","otherNames":[]},{"type":"DRUG","name":"Olodaterol (BI 1744)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Olodaterol (BI1744) Low","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Olodaterol (BI 1744) High","type":"EXPERIMENTAL"}],"summary":"This primary objective of this study is to compare two doses of BI 1744 CL inhalation solution delivered by the Respimat® inhaler once daily to placebo in patients with chronic obstructive pulmonary disease (COPD).","primaryOutcome":{"measure":"Forced Expiratory Volume in One Second (FEV1) Area Under Curve 0-3 Hour (h) (AUC 0-3h) Response at Day 85 (12 Weeks)","timeFrame":"1 hour (h) and 10 minutes (min) prior to dose on the first day of randomized treatment (baseline) to -10 min, 5 min, 15 min, 30 min, 1 h, 2 h, and 3 h relative to dose on Day 85","effectByArm":[{"arm":"Placebo","deltaMin":0.008,"sd":0.013},{"arm":"Olo 5 mcg qd","deltaMin":0.159,"sd":0.013},{"arm":"Olo 10 mcg qd","deltaMin":0.152,"sd":0.013}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":51,"countries":["United States","China","Germany","Taiwan"]},"refs":{"pmids":["32943047","32848381","30077810","24966672"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":216},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Upper respiratory tract infection","Headache"]}}